Abeona Therapeutics Inc (ABEO)
4.40
-0.20
(-4.35%)
USD |
NASDAQ |
May 17, 16:00
4.42
+0.02
(+0.45%)
After-Hours: 20:00
Abeona Therapeutics Cash and Short Term Investments (Quarterly): 62.34M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 62.34M |
December 31, 2023 | 52.23M |
September 30, 2023 | 53.75M |
June 30, 2023 | 36.77M |
March 31, 2023 | 40.36M |
December 31, 2022 | 52.15M |
September 30, 2022 | 18.17M |
June 30, 2022 | 20.10M |
March 31, 2022 | 31.32M |
December 31, 2021 | 45.02M |
September 30, 2021 | 67.00M |
June 30, 2021 | 77.56M |
March 31, 2021 | 86.77M |
December 31, 2020 | 95.03M |
September 30, 2020 | 96.87M |
June 30, 2020 | 107.88M |
March 31, 2020 | 116.04M |
December 31, 2019 | 129.26M |
September 30, 2019 | 47.92M |
June 30, 2019 | 62.51M |
March 31, 2019 | 68.31M |
December 31, 2018 | 84.97M |
September 30, 2018 | 112.22M |
June 30, 2018 | 119.84M |
March 31, 2018 | 132.00M |
Date | Value |
---|---|
December 31, 2017 | 137.75M |
September 30, 2017 | 56.52M |
June 30, 2017 | 58.30M |
March 31, 2017 | 63.21M |
December 31, 2016 | 69.14M |
September 30, 2016 | 31.18M |
June 30, 2016 | 34.30M |
March 31, 2016 | 37.40M |
December 31, 2015 | 40.14M |
September 30, 2015 | 43.28M |
June 30, 2015 | 30.41M |
March 31, 2015 | 7.948M |
December 31, 2014 | 11.52M |
September 30, 2014 | 0.165M |
June 30, 2014 | 0.055M |
March 31, 2014 | 0.299M |
December 31, 2013 | 0.424M |
September 30, 2013 | 0.899M |
June 30, 2013 | 1.798M |
March 31, 2013 | 0.05M |
December 31, 2012 | 0.396M |
September 30, 2012 | 0.106M |
June 30, 2012 | 0.588M |
March 31, 2012 | 1.365M |
December 31, 2011 | 2.46M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
18.17M
Minimum
Sep 2022
129.26M
Maximum
Dec 2019
64.95M
Average
58.05M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
T2 Biosystems Inc | 6.208M |
INVO Bioscience Inc | 0.2324M |
Perspective Therapeutics Inc | 180.65M |
Electromed Inc | 11.71M |
Xtant Medical Holdings Inc | 4.547M |